EPS: As of FY2025 Q2, the actual value is USD 0.08.<h3>Segment Revenue</h3><ul><li>Interest Income on Investments Held in the Trust Account: $2,129,729 for the three months ended June 30, 2025, and $3,315,677 for the six months ended June 30, 2025.</li></ul><h3>Operational Metrics</h3><ul><li>Net Income (Loss): $1,955,328 for the three months ended June 30, 2025, compared to a net loss of $43,302 for the same period in 2024. For the six months ended June 30, 2025, net income was $2,948,728, compared to a net loss of $43,302 for the same period in 2024.</li><li>General and Administrative Costs: $144,401 for the three months ended June 30, 2025, compared to $43,302 for the same period in 2024. For the six months ended June 30, 2025, general and administrative costs were $308,884, compared to $43,302 for the same period in 2024.</li><li>Administrative Expenses - Related Party: $30,000 for the three months ended June 30, 2025, and $58,065 for the six months ended June 30, 2025.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Provided by Operating Activities: $52,578 for the six months ended June 30, 2025.</li><li>Net Cash Used in Investing Activities: - $200,000,000 for the six months ended June 30, 2025.</li><li>Net Cash Provided by Financing Activities: $199,972,422 for the six months ended June 30, 2025.</li></ul><h3>Unique Metrics</h3><ul><li>Cash and Cash Equivalents Held in Trust Account: $203,315,677 as of June 30, 2025.</li><li>Deferred Offering Costs: $217,609 as of December 31, 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company intends to effect a merger, capital share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses, focusing on financial services, healthcare, real estate services, technology, and software industries.</li><li>Non-Core Business: The company has entered into a business combination agreement with BSTR Holdings, Inc. and other related entities, with the transactions expected to be consummated prior to the end of the combination period.</li><li>Priority: The company has until January 8, 2027, to consummate the business combination. If unable to complete the business combination by the end of the combination period, the company will cease all operations except for the purpose of winding up, redeem the public shares, and dissolve and liquidate.</li></ul>

Cantor Equity Partners | 10-Q: FY2025 Q2 EPS: USD 0.08